A novel and accurate microfluidic assay of CD62L in bladder cancer serum samples

Analyst, 2018, Advance Article DOI: 10.1039/C8AN01463A, PaperGayatri S. Phadke, Jennifer E. Satterwhite-Warden, Dharamainder Choudhary, John A. Taylor, James F. Rusling A magnetic bead-based, microfluidic immunoarray of CD62L can distinguish between low- and high-grade bladder cancer tumors. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - Analyst latest articles - October 8, 2018 Category: Chemistry Authors: Gayatri S. Phadke Source Type: research